Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study ; volume:19 ; number:1 ; day:28 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
Lipids in health and disease ; 19, Heft 1 (28.7.2020), 1-8, 12.2020
- Creator
-
Rezaei, Mansour
Fakhri, Negin
Pasdar, Yahya
Moradinazar, Mehdi
Najafi, Farid
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-020-01354-z
- URN
-
urn:nbn:de:101:1-2020092421195883395666
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rezaei, Mansour
- Fakhri, Negin
- Pasdar, Yahya
- Moradinazar, Mehdi
- Najafi, Farid
- SpringerLink (Online service)
Other Objects (12)
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
Lipid profile and dyslipidemia among school-age children in urban Ghana
Blood pressure trajectory modeling in childhood: birth-cohort study
Diabetes Dyslipidemia
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Worldwide Dyslipidemia Guidelines
Temporal changes in lipid concentrations and the prevalence of dyslipidemia among individuals with diabetes, prediabetes, and normal blood glucose from 2011 to 2015
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
Lipid profile and dyslipidemia among school-age children in urban Ghana
Blood pressure trajectory modeling in childhood: birth-cohort study
Diabetes Dyslipidemia
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Worldwide Dyslipidemia Guidelines
Temporal changes in lipid concentrations and the prevalence of dyslipidemia among individuals with diabetes, prediabetes, and normal blood glucose from 2011 to 2015
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
Lipid profile and dyslipidemia among school-age children in urban Ghana
Blood pressure trajectory modeling in childhood: birth-cohort study
Diabetes Dyslipidemia
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Worldwide Dyslipidemia Guidelines